TrendingWallStreet.com Initiates Research on EGY, GLER, PGLO, and ARNA

Whether you are a bull or bear, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Vaalco Energy Inc. (NYSE: EGY) shares closed up 16.27 percent on Friday with a little over 1 million shares traded. The stock traded in between $5.09 and 5.94 that day. The sock’s intra-day low that day was just 6 cents shy of hitting the stocks 52-week low of $5.03. Last Thursday the company reported net income attributable to VAALCO of $2.4 million or $0.04 per diluted share for the third quarter of 2013 compared to net income attributable to VAALCO of $0.1 million or $0.00 per diluted share for the comparable period in 2012.

Get more information on Vaalco Energy Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/EGY

Global Earth Energy, Inc. (OTC: GLER) shares closed down 26.47 percent on about 250 million shares traded on Friday. The stock traded in a range of 0.0019 - 0.0040 that day. Earlier in the week, the company’s partner Hawk Manufacturing (HAWK) announced a partnership with Southstar Capital of Charleston, SC. Southstar will be providing Hawk Manufacturing and Trump Equipment Company additional operating capital.

Get more information on Global Earth Energy, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/GLER

Pan Global Corp. (OTC: PGLO) shares finally closed in the green up 27.60% on Friday, after retracing all week. Shares had seen a loss of roughly 95% last week up until Friday's gains. The stock traded about 2.6 million shares on Friday.

Get more information on Pan Global Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/PGLO

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares closed up 17.40 percent on Friday and traded in between 4.40 and 4.98 a share. The stock traded about 16.3 million shares that day. The Company reported third-quarter earnings report. Revenue soared by 140%, although the company's net loss widened from year-ago levels.

Get more information on Arena Pharmaceuticals, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ARNA

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.